Journal Report

ONCOIMMUNOLOGY

Download PDF
Journal Information
Journal Title
ONCOIMMUNOLOGY
Publisher
TAYLOR & FRANCIS INC
ISSN
2162-402X
E-ISSN
2162-402X
Database
Clarivate
Domain
Health Sciences, Life Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
RIG-I is essential for radiation-induced IFN-β production and PD-L1/PD-L2 upregulation in HPV-negative head and neck squamous cell carcinoma cells
Anna Gottwald, Marlen Haderlein, Christina B. Brunner et al.
2026-11-6 Vol. 15 Issue 1
DOI: 10.1080/2162402x.2026.2757877
Alteration of macrophage infiltrates in the tumor immune microenvironment following Janus kinase 1 (JAK) inhibition: analysis from a prospective clinical trial in Leiomyosarcoma
Michael J. Wagner, Lee D. Cranmer, Elizabeth T. Loggers et al.
2026-11-6 Vol. 15 Issue 1
DOI: 10.1080/2162402x.2026.2755668
Cancer patient outcomes correlate with activating-KIR/ligand repertoires associated with distinct NK cell transcriptomic profiles
Inmaculada Ruiz-Lorente, Andrés Vallejo-Pulido, Alicia López-Abad et al.
2026-11-4 Vol. 15 Issue 1
DOI: 10.1080/2162402x.2026.2756722
Local ablative treatment for oligoprogression during immunotherapy in metastatic non-small-cell lung cancer: a systematic review and meta-analysis
Ismaell Massalha, Adham Hijab, Reem Zabit et al.
2026-10-31 Vol. 15 Issue 1
DOI: 10.1080/2162402x.2026.2756061
Irradiated dendritic cell subsets retain key immune capabilities and anti-tumor immunity is not strictly dependent on cDC1
Teresa Irianto, Ann-Sophie Flohr, Clara Reichardt et al.
2026-10-29 Vol. 15 Issue 1
DOI: 10.1080/2162402x.2026.2743436
Sialic acid <i>cis</i> -ligands as modulators of Siglec function in cancer immunity
Anne H.C. Valk, Matthia G.M. Boros, Fabian Schuurmans et al.
2026-10-29 Vol. 15 Issue 1
DOI: 10.1080/2162402x.2026.2752647
Mast cell phenotypic remodeling toward a PD-1-positive, Chymase-negative phenotype is associated with metastatic melanoma and poor survival
Julián A. Gajón, Laura C. Bonifaz, Ezequiel Fuentes-Panana et al.
2026-10-23 Vol. 15 Issue 1
DOI: 10.1080/2162402x.2026.2752644
Real-world comparative outcomes of first-line immune combinations (ICI–ICI vs ICI–TKI) in metastatic renal cell carcinoma with sarcomatoid features
Sara Elena Rebuzzi, Fabrizio Di Costanzo, Roberto Filippi et al.
2026-10-22 Vol. 15 Issue 1
DOI: 10.1080/2162402x.2026.2751848
Glioblastoma immune landscape remodeling following treatment with CD70-targeted CAR-T cells
Alexandros Kourtesakis, Dennis Alexander Agardy, Clara Tejido Dierssen et al.
2026-10-18 Vol. 15 Issue 1
DOI: 10.1080/2162402x.2026.2745295
Biomarkers of subclinical cholestasis predict cancer immunotherapy outcomes
Anne-Laure Mallard de La Varende, Marine Fidelle, Guido Kroemer et al.
2026-10-15 Vol. 15 Issue 1
DOI: 10.1080/2162402x.2026.2748140
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 9, 2026 13:50